EGFR-IN-215 (Compound 019) is an EGFR inhibitor with IC 50 values for the L858R BaF3 and L858R/C797S mutant forms of both ≤ 0.25 μM. EGFR-IN-215 can be used in cancer research.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > EGFR
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。